Reply to S.A. Upadhyaya

Alyssa T Reddy¹, Mark D Krailo¹, Allen B Buxton¹+14

• ¹Alyssa T. Reddy, MD, University of California San Francisco, CA; Mark D. Krailo, PhD, Keck School of Medicine, University of Southern California, Los Angeles, CA; Allen B. Buxton, MS, Children's Oncology Group, Monrovia, CA; Douglas R. Strother, MD, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Annie Huang, MD, PhD, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, ON, Canada; Tianni Zhou, PhD, California State University at Long Beach, Long Beach, CA; Alexander R. Judkins, MD, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA; Peter C. Burger, MD, Johns Hopkins University, Baltimore, MD; Ian F. Pollack, MD, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, Pittsburgh, PA; Chris Williams-Hughes, BS, Children's Oncology Group, Monrovia, CA; Maryam Fouladi, MD, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Ben Ho, MSc, Hospital for Sick Children, Toronto, ON, Canada; Claire M. Mazewski, MD, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA; Victor A. Lewis, MD, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Louis-Gilbert Vezina, MD, The George Washington University School Medicine and Health Sciences, Washington, DC; Timothy N. Booth, MD, University of Texas Southwestern, Dallas, TX; and Anita Mahajan, MD, Mayo Clinic, Rochester, MN.